Quick recap
Growth strategy focused on China's infant milk formula market
Full-year results show double-digit revenue and earnings growth
China sales up 38%, record market share in China label IMFMarketing investment up 13% to $260m boosts
China brand healthTotal IMF sales rise 8% despite market decline of 14%
China IMF market decline due to fewer newborns and increased competition
Revenue grows 10.1% to $1,592.9 million with varied regional sales
EBITDA up 11.8% to $219.3 million
NPAT up 26.2% to $144.8 million
Earnings per share rise 28.7% to 21.2 cents
Company expects growth in FY24 despite market challenges.
- Forums
- ASX - By Stock
- A2M
- Ann: FY23 Annual Report
Ann: FY23 Annual Report, page-4
-
-
- There are more pages in this discussion • 109 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add A2M (ASX) to my watchlist
|
|||||
Last
$6.85 |
Change
-0.060(0.87%) |
Mkt cap ! $4.952B |
Open | High | Low | Value | Volume |
$6.91 | $6.93 | $6.81 | $7.337M | 1.070M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 4252 | $6.84 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.86 | 10763 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 4252 | 6.840 |
1 | 1829 | 6.830 |
4 | 18364 | 6.810 |
6 | 39047 | 6.800 |
1 | 5601 | 6.790 |
Price($) | Vol. | No. |
---|---|---|
6.860 | 10763 | 3 |
6.870 | 70 | 1 |
6.880 | 7000 | 1 |
6.900 | 5985 | 3 |
6.910 | 200 | 1 |
Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
Featured News
A2M (ASX) Chart |